Myriad Genetics vs Orthofix Medical
Myriad Genetics and Orthofix Medical are similar in size: $825m and $822m of revenue in their latest fiscal years. Orthofix Medical grew faster (2.9% against -1.6%). Orthofix Medical kept more of each dollar of sales as profit: a net margin of -11.2% against -44.4%.
| Latest fiscal year | Myriad GeneticsMYGN, 2025 | Orthofix MedicalOFIX, 2025 |
|---|---|---|
| Revenue | $825m | $822m |
| Revenue growth | -1.6% | 2.9% |
| Net income | −$366m | −$92.2m |
| Operating margin | -47.0% | — |
| Net margin | -44.4% | -11.2% |
| Return on equity | -68.5% | -19.3% |
| Free cash flow | $1.8m | −$1.3m |
| Cash | $150m | $82.0m |
| Total debt | $125m | $157m |
| Debt to equity | 34.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 2,700 | 1,605 |
| Market value | $567m | $355m |
| Price vs our value range | — | — |
| Moat score | 26 (Weak) | 41 (Weak) |
| Insider trades, 12 months | 5 buys, 1 sales | 18 buys, 28 sales |